US 7612065
Inhibitors of c-JUN N-terminal kinases (JNK)
granted A61PA61P25/16
Quick answer
US patent 7612065 (Inhibitors of c-JUN N-terminal kinases (JNK)) held by Vertex Pharmaceuticals Incorporated expires Mon Oct 29 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Nov 03 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 29 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61P, A61P25/16